These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31278167)

  • 1. Risk-Based Newborn Drug Testing in a Setting With a Low Prevalence of Maternal Drug Use.
    Wood KE; McMillin GA; Krasowski MD
    Hosp Pediatr; 2019 Aug; 9(8):593-600. PubMed ID: 31278167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center.
    Palmer KL; Wood KE; Krasowski MD
    Clin Biochem; 2017 Apr; 50(6):255-261. PubMed ID: 27890824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy.
    González-Colmenero E; Concheiro-Guisán A; Lorenzo-Martínez M; Concheiro M; Lendoiro E; de-Castro-Ríos A; Cañizo-Vázquez D; Martínez-Reglero C; Fernández-Lorenzo JR
    J Addict Dis; 2021; 39(2):175-182. PubMed ID: 33043834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey.
    Montgomery DP; Plate CA; Jones M; Jones J; Rios R; Lambert DK; Schumtz N; Wiedmeier SE; Burnett J; Ail S; Brandel D; Maichuck G; Durham CA; Henry E; Christensen RD
    J Perinatol; 2008 Nov; 28(11):750-3. PubMed ID: 18596707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy.
    Lendoiro E; González-Colmenero E; Concheiro-Guisán A; de Castro A; Cruz A; López-Rivadulla M; Concheiro M
    Ther Drug Monit; 2013 Jun; 35(3):296-304. PubMed ID: 23666580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection.
    Concheiro M; González-Colmenero E; Lendoiro E; Concheiro-Guisán A; de Castro A; Cruz-Landeira A; López-Rivadulla M
    Ther Drug Monit; 2013 Aug; 35(4):502-9. PubMed ID: 23851907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of in utero cannabis exposure by umbilical cord analysis.
    Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
    Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
    Krotulski AJ; Mohr ALA; Friscia M; Logan BK
    J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn drug testing practices in Iowa birthing hospitals.
    Wood KE; Smith P; Krasowski MD
    J Neonatal Perinatal Med; 2017; 10(4):445-450. PubMed ID: 29286931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal drug use in Minneapolis-St Paul, Minn. A 4-year trend.
    Yawn BP; Thompson LR; Lupo VR; Googins MK; Yawn RA
    Arch Fam Med; 1994 Jun; 3(6):520-7. PubMed ID: 8081532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah.
    Smid MC; Allshouse AA; McMillin GA; Nunez K; Cavin T; Worden J; Buchi K; Muniyappa B; Varner MW; Cochran G; Metz TD
    Obstet Gynecol; 2022 Aug; 140(2):153-162. PubMed ID: 35852263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal illicit drug screening practices in mother-newborn dyads at a university hospital serving rural/semi-urban communities: translation of research to quality improvement.
    Oral R; Koc F; Bayman EO; Assad A; Austin A; Strang T; Bayman L
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2441-6. PubMed ID: 22716202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs of abuse in maternal hair and paired neonatal meconium: an objective assessment of foetal exposure to gestational consumption.
    Joya X; Marchei E; Salat-Batlle J; García-Algar O; Calvaresi V; Pacifici R; Pichini S
    Drug Test Anal; 2016 Aug; 8(8):864-8. PubMed ID: 26627903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Opioid and Stimulant Exposure In Utero Through Targeted and Untargeted Metabolomics Analysis of Umbilical Cords.
    Mamillapalli SS; Smith-Joyner A; Forbes L; McIntyre K; Poppenfuse S; Rushing B; Strom C; Danell AS; May L; Kuehn D; Kew K; Ravisankar S
    Ther Drug Monit; 2020 Oct; 42(5):787-794. PubMed ID: 32142018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy.
    Concheiro M; Lendoiro E; de Castro A; Gónzalez-Colmenero E; Concheiro-Guisan A; Peñas-Silva P; Macias-Cortiña M; Cruz-Landeira A; López-Rivadulla M
    Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.
    Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD
    J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
    Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
    J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
    Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
    J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry.
    Marin SJ; Metcalf A; Krasowski MD; Linert BS; Clark CJ; Strathmann FG; McMillin GA
    Ther Drug Monit; 2014 Feb; 36(1):119-24. PubMed ID: 24061447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.